Official announcements
Search narrowed by
messages in brief
|
04/04/2016
Due to legal requirements (Reg. (EC) 726/2004, Article 25a), EMA is obliged to set up a database for periodic safety update reports (PSUR) and the associated opinions. All PSUR procedures must be submitted electronically (according to Reg. 726/2004, Article 107b paragraph 1 and Article 28(2)). Since September 1, 2015, the use of the xml file for…
messages in brief
|
22/03/2016
Recently, pyrrolizidine alkaloids have also been detected in herbal preparations made from plants that do not biosynthesize pyrrolizidine alkaloids. Studies suggest that contamination with weeds may be responsible. Since even very few individuals of weeds (such as species of the genus Senecio , greiseweed) can lead to toxicologically relevant…
messages in brief
|
04/12/2015
As of 1st January 2016 it will be mandatory for companies submitting applications for European and National Procedures (human and veterinary) to use the electronic application form (eAF). Please find further information at http://www.basg.gv.at/en/medicines/electronic-application/electronic-application-form/ .
Safety warnings
|
messages in brief
|
27/11/2015
A re-examination of the safety and efficacy of human papillomavirus vaccines (HPV vaccines) has been completed. After evaluation of the current data by the Pharmacovigilance Risk Assessment Committee (PRAC), no causal association between the HPV vaccines and the occurrence of complex regional pain syndrome (CRPS) or postural orthostatic tachycardia…
Safety warnings
|
messages in brief
|
22/10/2015
The Federal Agency informs about recommendations of the Committee for Risk Assessment and Pharmacovigilance (PRAC, BASG initial notification 13.3.2015) and the subsequent decision within the European risk assessment procedure according to Article 31 of Directive 2001/83/EC regarding the use of codeine for cough and cold in children (update). Action…
messages in brief
|
29/09/2015
Dear registration holder,due to a technical malfunction in the period from 20.09.2015 (15h) until 28.09.2015 (12h) an electronic transmission of adverse event reports to BASG/AGES MEA was not possible. Therefore, you did not receive an acknowledgement for any case reports transmitted during this period. It is therefore absolutely necessary to…
messages in brief
|
27/08/2015
Small import" of medicinal specialities according to § 11 para. 1 Z 7 of the Austrian Medicinal Products Import ActThe Federal Office for Safety in Health Care takes the liberty to state with regard to the exceptional provision of the so-called "small import" of medicinal specialities from the EEA by public pharmacies according to § 11 para. 1 Z 7…
Safety warnings
|
messages in brief
|
01/07/2015
The European Medicines Agency (EMA) recommends new measures to ensure the safe and successful use of epinephrine auto-injectors. Introduction of new training material Patients should always carry two auto-injectors for safety. Measures at EU level Epinephrine auto-injectors are used for emergency self-treatment of anaphylaxis (severe allergic…
messages in brief
|
30/06/2015
On May 12, 2015, the European Medicines Agency (EMA) announced that - in accordance with Article 27 of Regulation (EC) No. 726/2004 - starting on July 1, 2015, the search for suspected ADRs published in the scientific literature will be conducted by the EMA in selected literature sources and for certain active ingredients or combinations of active…
messages in brief
|
23/06/2015
As of June 25, Austrian pharmacies will be allowed to sell over-the-counter medicines over the Internet - BMG and BASG launch educational campaign